Crop Life Science
CLSL NSE
Crop Life Science
ChemicalsNSE: CLSL Pesticides & Agrochemicals
Key Fundamentals
SMEPesticides & AgrochemicalsChemicalsMarket Cap
₹142 Cr
Volatility
Moderate
P/E Ratio
21.9
EBITDA
₹19.50 Cr
Return on Equity
7.38%
Debt to Equity
0.67
Book Value
₹49.15
52W High
₹92.25
52W Low
₹39.05
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Weaknesses
2- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 9.02% over last 3 years.
Growth Rate
Revenue Growth
3.62% lower than
3Y
Net Income Growth
16.07% lower than
3Y
Cash Flow Change
-409% lower than
3Y
ROE
7.11% lower than
3Y
ROCE
10.42% lower than
3Y
EBITDA Margin (Avg.)
8.46% lower than
3Y
Quarterly Results
| Particulars | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 79 | 52 | 97 | 101 | 106 | 94 | 120 | 87 |
| Expenses | 75 | 45 | 91 | 95 | 98 | 87 | 112 | 78 |
| Operating Profit | 5 | 7 | 6 | 6 | 8 | 8 | 8 | 9 |
| OPM % | 6% | 13% | 7% | 6% | 8% | 8% | 7% | 10% |
| Other Income | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
| Interest | 1 | 2 | 1 | 2 | 2 | 2 | 3 | 3 |
| Depreciation | 1 | 3 | 2 | 2 | 2 | 2 | 2 | 2 |
| PBT | 2 | 3 | 4 | 4 | 4 | 5 | 4 | 6 |
| Tax % | 62% | -1% | 20% | 32% | 23% | 30% | 26% | 32% |
| Net Profit | 1 | 3 | 3 | 3 | 3 | 3 | 3 | 4 |
| EPS in Rs | 0.78 | 2.61 | 1.96 | 1.56 | 2.01 | 1.86 | 1.88 | 2.19 |
Profit & Loss
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 126 | 107 | 94 | 130 | 191 | 196 | 203 |
| Expenses | 118 | 98 | 86 | 118 | 178 | 180 | 186 |
| Operating Profit | 8 | 9 | 8 | 12 | 13 | 16 | 17 |
| OPM % | 7% | 8% | 8% | 9% | 7% | 8% | 8% |
| Other Income | 0 | 1 | 0 | 1 | 2 | 1 | 2 |
| Interest | 2 | 2 | 2 | 3 | 3 | 5 | 5 |
| Depreciation | 2 | 3 | 2 | 4 | 3 | 3 | 3 |
| PBT | 5 | 5 | 4 | 6 | 8 | 9 | 10 |
| Tax % | 30% | 25% | 25% | 27% | 26% | 26% | 29% |
| Net Profit | 3 | 4 | 3 | 4 | 6 | 7 | 7 |
| EPS in Rs | 2.69 | 3.08 | 2.34 | 3.39 | 3.52 | 3.86 | 4.08 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 12 | 12 | 12 | 12 | 17 | 17 | 17 |
| Reserves | 18 | 21 | 24 | 29 | 55 | 61 | 68 |
| Borrowings | 16 | 18 | 22 | 27 | 34 | 44 | 57 |
| Other Liabilities | 31 | 35 | 37 | 34 | 67 | 55 | 63 |
| Total Liabilities | 76 | 86 | 95 | 102 | 172 | 178 | 205 |
| Fixed Assets | 12 | 13 | 11 | 16 | 22 | 22 | 16 |
| CWIP | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 12 | 13 | 13 |
| Other Assets | 64 | 73 | 82 | 86 | 138 | 142 | 177 |
| Total Assets | 76 | 86 | 95 | 102 | 172 | 178 | 205 |
Cash Flow
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | 3 | 4 | 0 | 2 | -8 | -2 | -8 |
| Investing | -1 | -2 | -2 | -4 | -16 | -4 | 2 |
| Financing | -3 | -1 | 1 | 1 | 24 | -5 | -9 |
| Net Cash Flow | -1 | 1 | -1 | -2 | 0 | -11 | -15 |
| Free Cash Flow | 2 | 1 | -2 | -3 | -13 | -5 | -4 |
| CFO/OP | 46 | 58 | 11 | 34 | -49 | 3 | -31 |
Ratios
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 80 | 89 | 143 | 92 | 148 | 129 | 134 |
| Inventory Days | 93 | 159 | 137 | 104 | 99 | 126 | 170 |
| Days Payable | 72 | 108 | 137 | 79 | 131 | 113 | 127 |
| Cash Conversion Cycle | 100 | 140 | 143 | 116 | 117 | 141 | 177 |
| Working Capital Days | 50 | 74 | 93 | 86 | 86 | 89 | 105 |
| ROCE % | — | 14% | 11% | 14% | 13% | 12% | 12% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Crop Life Science insights
41 extracted metrics + investor summaries across FY20–FY26.
Documents
1
General Updates
4 Sep - Letters sent to non-email shareholders; 20th AGM on 23 Sep 2026 via VC/OAVM. 4 Sep - Letters sent to non-email shareholders; 20th AGM on 23 Sep 2026 via VC/OAVM.
2
Copy of Newspaper Publication
27 Aug - 20th AGM on September 23, 2026 at 3:30 PM; e-voting from September 19-22, 2026. 27 Aug - 20th AGM on September 23, 2026 at 3:30 PM; e-voting from September 19-22, 2026.
3
Shareholders meeting
26 Aug - AGM on 23 Sep 2026 considers ₹125 crore related-party transaction, two independent director appointments, and FY26 financials. 26 Aug - AGM on 23 Sep 2026 considers ₹125 crore related-party transaction, two independent director appointments, and FY26 financials.
4
Outcome of Board Meeting
24 Aug - Board approved FY26 report, fixed AGM for 23 Sept 2026, and deferred overseas subsidiary proposal. 24 Aug - Board approved FY26 report, fixed AGM for 23 Sept 2026, and deferred overseas subsidiary proposal.
5
Outcome of Board Meeting
30 Jul - Board appointed two independent directors and named cost and internal auditors for FY27. 30 Jul - Board appointed two independent directors and named cost and internal auditors for FY27.
Frequently Asked Questions about Crop Life Science
What does Crop Life Science Ltd do?
Incorporated in 2006, Crop Life Sciences
Ltd manufactures and deals in pesticides, insecticides, herbicide, fertilizers and allied products related to research and technical formulations[1]
Where is Crop Life Science Ltd (CLSL) listed?
Crop Life Science Ltd trades as CLSL on the NSE.
Which sector does Crop Life Science Ltd belong to?
Crop Life Science Ltd is classified under the Chemicals sector, in the Pesticides & Agrochemicals industry.
What is the market capitalisation of Crop Life Science Ltd?
Crop Life Science Ltd has a market capitalisation of ₹142.26 Cr, which places it in the Small Cap band.
What is the PE ratio of Crop Life Science Ltd?
Crop Life Science Ltd trades at a PE ratio of 21.90, against a book value of ₹49.15 per share.
What is the 52-week high and low of Crop Life Science Ltd?
Over the last 52 weeks Crop Life Science Ltd has traded between ₹39.05 and ₹92.25.
What is the Return on Equity (ROE) of Crop Life Science Ltd?
Crop Life Science Ltd reported a return on equity of 7.38%. Its debt-to-equity ratio is 0.67.
Company Information
Incorporated in 2006, Crop Life Sciences Ltd manufactures and deals in pesticides, insecticides, herbicide, fertilizers and allied products related to research and technical formulations[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/CLSL.md for Crop Life Science Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.